CDH17 and gastric cancer: In the CDH17 immunohistochemical analysis of gastric cancer specimens, the percentage of CDH17-positive primary cancer and positive LN metastasis [primary (+)/LN (+)] was 80%, suggesting that most metastatic regions are positive for CDH17 when the primary regions are CDH17-positive.